These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3084240)
1. Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin. Machka K; Röbl M; Braveny I Eur J Clin Microbiol; 1986 Feb; 5(1):115-8. PubMed ID: 3084240 [TBL] [Abstract][Full Text] [Related]
2. Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin. Machka K; Dietz R Eur J Clin Microbiol; 1983 Oct; 2(5):496-500. PubMed ID: 6315425 [TBL] [Abstract][Full Text] [Related]
3. Comparative synergistic activity of netilmicin-piperacillin versus gentamicin-piperacillin. Machka K; Baierl W; Braveny I Eur J Clin Microbiol; 1982 Aug; 1(4):238-42. PubMed ID: 6217066 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of novel antipseudomonal drugs using the serum bactericidal activity test. Braveny I; Machka K; Milatovic D Eur J Clin Microbiol; 1986 Feb; 5(1):119-23. PubMed ID: 3084241 [TBL] [Abstract][Full Text] [Related]
5. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa. Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802 [TBL] [Abstract][Full Text] [Related]
6. In vitro studies of the synergism of piperacillin and netilmicin against blood culture isolates. Arpi M; Jørgensen PE; Pedersen HF Chemotherapy; 1986; 32(1):68-74. PubMed ID: 3081304 [TBL] [Abstract][Full Text] [Related]
7. The in vitro activity of netilmicin against 357 clinical isolates of Enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. Digranes A; Dibb WL; Ostervold B Scand J Infect Dis Suppl; 1980; Suppl 23():30-3. PubMed ID: 6782655 [No Abstract] [Full Text] [Related]
8. Susceptibility of 327 clinical isolates to netilmicin. Digranes A; Ostervold B; Madsen ST; Solberg CO; Haeger K J Int Med Res; 1978; 6(5):409-13. PubMed ID: 100353 [TBL] [Abstract][Full Text] [Related]
9. [In vitro antibacterial activity of piperacillin-tazobactam in combination with netilmicin or amikacin against Enterobacteriaceae resistant to amoxicillin]. Duez JM; Siebor E; Pechinot A; Cordin X; Chamard-Neuwirth C; Kazmierczak A Pathol Biol (Paris); 1995 Mar; 43(3):208-14. PubMed ID: 7675548 [TBL] [Abstract][Full Text] [Related]
10. In vitro synergism of ceftriaxone combined with aminoglycosides against Pseudomonas aeruginosa. Laverdière M; Gallimore B; Restieri C; Poonia K; Chow AW Diagn Microbiol Infect Dis; 1994 May; 19(1):39-46. PubMed ID: 7956011 [TBL] [Abstract][Full Text] [Related]
11. Effect of increasing doses of amikacin with or without piperacillin in the serum bactericidal test. Lagast H; Pascual-Lopez A; Dejace P; Klastersky J Eur J Clin Microbiol; 1986 Feb; 5(1):98-102. PubMed ID: 3084248 [TBL] [Abstract][Full Text] [Related]
12. Comparative in vitro activity of several antimicrobial agents against selected clinical isolates. Liebowitz LD; Saunders J; Chalkley LJ; Koornhof HJ S Afr Med J; 1990 Apr; 77(8):395-400. PubMed ID: 2109875 [TBL] [Abstract][Full Text] [Related]
13. [Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections]. Salvo S; Falcidia A; Mirone L Minerva Med; 1987 Jan; 78(2):71-7. PubMed ID: 3543744 [TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibilities of mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients against azthreonam, netilmicin and piperacillin. Flournoy DJ; Cox FR Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):487-9. PubMed ID: 6439964 [TBL] [Abstract][Full Text] [Related]
15. In-vitro antimicrobial activity of enoxacin in combination with eight other antibiotics against Pseudomonas aeruginosa, Enterobacteriaceae and Staphylococcus aureus. Baltch AL; Bassey C; Fanciullo G; Smith RP J Antimicrob Chemother; 1987 Jan; 19(1):45-8. PubMed ID: 3104277 [TBL] [Abstract][Full Text] [Related]
16. [Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics]. Fazli SA; Aksebzeci T Mikrobiyol Bul; 1989 Oct; 23(4):356-60. PubMed ID: 2488944 [TBL] [Abstract][Full Text] [Related]
17. Interactions of antimicrobial combinations in vitro: the relativity of synergism. Blaser J Scand J Infect Dis Suppl; 1990; 74():71-9. PubMed ID: 2129067 [TBL] [Abstract][Full Text] [Related]
18. Interaction of gentamicin, dibekacin, netilmicin and amikacin with various penicillins, cephalosporins, minocycline and new fluoro-quinolones against Enterobacteriaceae and Pseudomonas aeruginosa. Van der Auwera P J Antimicrob Chemother; 1985 Nov; 16(5):581-7. PubMed ID: 3935637 [TBL] [Abstract][Full Text] [Related]
19. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media. Digranes A; Dibb WL; Benonisen E; Ostervold B Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889 [TBL] [Abstract][Full Text] [Related]
20. Effect of azlocillin and piperacillin in subinhibitory and inhibitory concentrations on Staphylococcus aureus and Pseudomonas aeruginosa in broth, in serum and in the presence of human polymorphonuclear leukocytes. Bassler M; Depuis W; Utz E; Just HM; Daschner FD Eur J Clin Microbiol; 1983 Oct; 2(5):439-44. PubMed ID: 6416838 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]